Ready Capital Corp 5.75% NT REDEEM 15/02/2026 USD 25 RCC 深 沪
等待开盘 12-19 09:30:00 美东时间
24.9504
+0.010
+0.04%
华盛通- 最 高25.0166
- 今 开25.0166
- 成交量 1.13万股
- 最 低 24.90
- 昨 收 24.94
- 总市值 1.32亿
- 52周最高 25.7919
- 市盈率 静 --
- 换手率 0.21%
- 52周最低 22.9725
- 委 比 0.00%
- 总股本 527.41万
- 历史最高 25.7919
- 量 比 1.31
- 振 幅 0.47%
- 历史最低 17.5375
- 每 手 1
- 风险率 0.56%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Lightwave Logic, Kyverna Therapeutics And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
U.S. stock futures were lower this morning, with the Dow futures falling around...
12-16 21:06
远东股份旗下安缆助力BEST核聚变装置突破 高端电缆技术获验证
我国紧凑型聚变能实验装置BEST近日完成杜瓦底座安装，正式进入主机组装阶段。作为未来能源战略的核心技术，可控核聚变的突破不仅推动科研进步，更带动高端电缆、特种材...
10-25 15:34
Xencor Presents Initial Results From Ongoing Phase 1 Dose-Escalation Study Of Xmab819, ENPP3 X CD3 T-Cell Engaging Bispecific Antibody, In Patients With Advanced ccRCC, At AACR-NCI-EORTC
-- XmAb819 is well-tolerated in heavily pretreated patients with advanced ccRCC ---- 25% overall response rate (ORR) observed within the target dose range ---- First dose-expansion cohort has been selected; dose
10-25 00:31
19个独家品种厉害了！高端注射剂暴涨1377%，正大制药、信达、齐鲁亮眼，22款1类新药发力
精彩内容 抗体类药物是目前现代生物医药领域的重要疗法。米内网数据显示，2025H1中国三大终端六大市场抗体类药物销售额首破900亿元；公立医疗机构品牌TOP2...
10-22 16:39
Xencor To Present Initial Results From Ongoing Phase 1 Dose-Escalation Study Of Xmab819 In Patients With ccRCC At AACR-NCI-EORTC Conference 2025
-- Management to host webcast and conference call on Friday, October 24, 2025 --Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and
10-15 00:47
Why Is Arcus Biosciences Stock Trading Higher On Monday?
Arcus Biosciences reports casdatifan monotherapy data in renal cancer, showing a 35% response rate and median progression-free survival not yet reached.
10-07 02:23
Regency Centers Invites You to Join Its Third Quarter 2025 Earnings Conference Call
Regency Centers Corporation will announce its third quarter 2025 earnings results on October 28, 2025, after the market closes. The earnings release and supplementary information will be available on the investor relations section of its website. The company will host an earnings conference call on October 29, 2025, at 11:00 a.m. ET. Participants can dial into the call at 877-407-0789 or 201-689-8562. A webcast will be available on the Investor R...
09-30 20:15
In Vivo与Allo CAR-T：谁先攻克商业化堡垒？
（来源：抗体圈） 2020年前后，同种异体CAR-T（AlloCAR-T）疗法风头无两。作为传统自体CAR-T的升级方向，它承诺摆脱“一人一药”的定制化...
09-22 18:46
新吉奥房车（00805.HK）9月15日收盘平盘
证券之星消息，截至2025年9月15日收盘，新吉奥房车(00805.HK)报收于1.17港元，与上一交易日持平，成交量8.6万股，成交额10.13万港元。
09-15 18:12
